|
Unapproved analgesic sales stopped. (Esgic with Codeine)
FDA Consumer
|
April 1, 1990|
|
COPYRIGHT 1990 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.
(Hide copyright information)
Copyright
|
The federal government has told a drug manufacturer to stop selling a prescription painkiller because it is an unapproved new drug.
The analgesic, Esgic with Codeine, manufactured by Forest Pharmaceuticals, Inc., St. Louis, Mo., contains acetaminophen, caffeine, codeine, and butalbital (a barbiturate). Although FDA has approved each of these drugs individually, their combination in one product constitutes a new drug. Under FDA regulations, a new drug can't be marketed until the company submits-and FDA approves-a new drug application.
Forest Pharmaceuticals ...
|
|
Getting SMART: drug review in the computer age. (Submission Management and Review Tracking system provides better records) (includes related article on how to compile information for new drug application)
Magazine article from: FDA Consumer
; ...more complete understanding of how a new drug or biological product works, its benefits...promises. (See From Test Tube to Patient: New Drug Development in the United States, an FDA...To seek FDA marketing approval for a new drug, the drug's sponsor, usually a pharmaceutical...
|
|
Pipeline previews.(new drug profiles)
Magazine article from: Journal of Drugs in Dermatology
; New Drug Application 19-941/S14, S15 Approval Date...RX Indication of Use: Topical anesthetic New Drug Application 21-470 Approval Date: 12/24...Topical treatment of rosacea Abbreviated New Drug Application 75-209 Approval Date: 1/21...
|
|
Office of New Drug Chemistry to become 'Office of New Drug Quality Assessment' by April; reviewers to join inspections.(CMC)
Newspaper article from: Validation Times
; BALTIMORE -- FDA's Office of New Drug Chemistry (ONDC) is being restructured into the Office of New Drug Quality Assessment to facilitate the implementation...Pharmaceutical Science, said the Office of New Drug Quality Assessment will identify critical...
|
|
New drug for HIV patients.(HIV update)
Magazine article from: Medical Laboratory Observer
; ...study, all patients took their existing prescription drugs along with either the new drug or a placebo. After a period of some 24 weeks, the patients using the new drug had a 98% drop in the amount of HIV material in their blood compared to a 45...
|
|
|
Firm cited for averaging OOS outcomes in new drug testing.(Baxter Healthcare Corp., out-of-specification)(Brief Article)
Newspaper article from: Validation Times
; ...audit of the Round Lake, IL, plant disclosed averaging of OOS outcomes for stability tests involved in amended new drug and new drug applications. In two instances, the OOS outcome was for the color of the unnamed substance and the other two were...
|
|
New drug discovery and development.(Brief Article)(Book Review)
Magazine article from: SciTech Book News
; 9780470007501 New drug discovery and development. Lednicer, Daniel. John Wiley & Sons...histories to demonstrate the domino effect that the discovery of a new drug or drug category can have. He organizes the material by drug category...
|
|
|
New drug helps relieve chemotherapy-related symptoms. (Updates).(Brief Article)
Magazine article from: FDA Consumer
; ...cause patients to refuse further chemotherapy treatments. A new drug, recently approved by the FDA, can help prevent these symptoms...Fewer patients had symptoms of nausea and vomiting when the new drug was part of their treatment, compared with patients receiving...
|
|
|
FDA to review New Drug Application for Oracea.(PIPELINE PREVIEWS)
Magazine article from: Journal of Drugs in Dermatology
; ...Pharmaceuticals, Inc., announced that the FDA has accepted to review its New Drug Application for Oracea, an oral tetracycline medication developed to treat rosacea. The New Drug Application data was primarily based on two Phase 3 double-blinded placebo-controll...
|
|
Predictors of sexual risk-taking among new drug users.
Magazine article from: The Journal of Sex Research
; ...well-entrenched is much more limited. New drug users may be more difficult to identify...that compared to more established users, new drug users reported less injection use, less...greater levels of HIV risk among these new drug injectors than among their peers who had...
|
|
new drug Adenoscn(R)
Newspaper article from: BT Catalyst
; Medco Research Inc. of Research Triangle Park anticipates launching its new drug Adenoscn(R) new drug Adenoscn(R) in the next few months through its original partner, Fujisawa, USA. Medco had planned to launch...
|
Find more facts and information related to the
article "Unapproved analgesic sales stopped. (Esgic with ..."
